Back to search

Article

FABP3 methylation as a novel biomarker for the differentiation and classification of benign and malignant thyroid nodules

2025-01-24

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold>Differentiation between benign and malignant thyroid nodules has been a challenge in clinical practice. We aim to explore a novel biomarker to determine the malignancy of thyroid nodules. <bold>Materials and methods: </bold>In the discovery study, 32 tissue samples from benign thyroid nodule (BTN) and thyroid cancer (TC) patients were analyzed by Methylation 850...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
425d1b7d-c82b-5ee8-90a7-87814cfd0ad9
DOI
10.21203/rs.3.rs-5794576/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
FABP3 methylation as a novel biomarker for the differentiation and classification of benign and malignant thyroid nodulesDOI 10.21203/rs.3.rs-5794576/v1
Select a neighboring publication to make it the new centre.